Earnings ·
Bruker Corporation reported second quarter 2026 financial results on August 4, 2026
BRKRBruker Corp
Bruker Corporation reported second quarter 2026 financial results on August 4, 2026. Total revenue reached $838.5 million, a 5.2% increase year-over-year, driven by organic growth of 2.8%. The Scientific Instruments segment saw bookings rise 10% organically with a book-to-bill ratio exceeding 1.0x. GAAP diluted loss per share was $(0.41), reflecting a $134.9 million goodwill impairment charge, while non-GAAP diluted EPS improved to $0.49 from $0.32 in the prior year period. The company updated its full-year 2026 guidance, projecting revenues of $3.54 to $3.57 billion and non-GAAP EPS of $2.10 to $2.15. Bruker Corporation operates in the scientific instruments industry, providing analytical solutions for life science research, diagnostics, and semiconductor metrology.